Skip to main content
Clinical Trials/CTRI/2022/05/042865
CTRI/2022/05/042865
Not yet recruiting
未知

Melatonin as an adjuvant in managing sleep impairment in Opioid withdrawal patients- A Randomised Controlled Trial

Sri Guru Ram Rai Institute of Medical and Health Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sri Guru Ram Rai Institute of Medical and Health Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Sri Guru Ram Rai Institute of Medical and Health Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of Opioid Dependence Syndrome
  • 2\. Patients willing to give informed written consent.
  • 3\. Age of patient between 18 to 50 Years.

Exclusion Criteria

  • 1\)Patients with other psychiatric comorbidities
  • 2\)Patients with other co\-morbid debilitating illnesses
  • 3\)Patients with history of preexisting Sleep disorders (RLS , OSA, Insomnia and other sleep related disorders)
  • 4\). Patients kept on opioid agonist Treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials